110 related articles for article (PubMed ID: 18779754)
1. Inflammation, coronary artery disease, and hormones.
Lobo RA
Menopause; 2008; 15(6):1036-8. PubMed ID: 18779754
[No Abstract] [Full Text] [Related]
2. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
[TBL] [Abstract][Full Text] [Related]
3. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women.
Koh KK; Bui MN; Mincemoyer R; Cannon RO
Am J Cardiol; 1997 Dec; 80(11):1505-7. PubMed ID: 9399737
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
Os I; Os A; Sandset PM; Bølling S; Seljeflot I; Djurovic S; Westheim A
Cardiology; 2002; 98(1-2):6-12. PubMed ID: 12373040
[TBL] [Abstract][Full Text] [Related]
5. No effect of oral hormone replacement therapy on platelet function in postmenopausal women with coronary artery disease.
Håkan Wallén N; Li N; Eriksson-Berg M; Landgren BM; Schenck-Gustafsson K; Hjemdahl P
Thromb Haemost; 2006 Dec; 96(6):862-3. PubMed ID: 17139389
[No Abstract] [Full Text] [Related]
6. The time has come to stop letting the HERS tale wag the dogma.
Mendelsohn ME; Karas RH
Circulation; 2001 Nov; 104(19):2256-9. PubMed ID: 11696459
[No Abstract] [Full Text] [Related]
7. Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women.
Lamon-Fava S; Posfai B; Schaefer EJ
Am J Cardiol; 2003 Jan; 91(2):252-4. PubMed ID: 12521647
[No Abstract] [Full Text] [Related]
8. Current views of hormone therapy for the management and treatment of postmenopausal women.
Stanczyk FZ; Bhavnani BR
J Steroid Biochem Mol Biol; 2014 Jul; 142():1-2. PubMed ID: 24463311
[No Abstract] [Full Text] [Related]
9. Consortium for the Assessment of Research on Progestins and Estrogens (CARPE) Fort Worth, Texas August 1-3, 2003.
Simpkins JW; Singh M
J Womens Health (Larchmt); 2004 Dec; 13(10):1165-8. PubMed ID: 15650349
[No Abstract] [Full Text] [Related]
10. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.
Zanger D; Yang BK; Ardans J; Waclawiw MA; Csako G; Wahl LM; Cannon RO
J Am Coll Cardiol; 2000 Nov; 36(6):1797-802. PubMed ID: 11092646
[TBL] [Abstract][Full Text] [Related]
11. Comment on 'Effect of conjugated estrogen versus conjugated estrogen associated with medroxyprogesterone acetate in postmenopausal women on internal carotid artery pulsatility index: a randomized pilot study'.
Weiping L; Chenxing L; Enfeng Z
J Obstet Gynaecol Res; 2012 Mar; 38(3):611-2. PubMed ID: 22353571
[No Abstract] [Full Text] [Related]
12. Hormone replacement therapy.
Med Lett Drugs Ther; 2002 Sep; 44(1138):78. PubMed ID: 12238487
[No Abstract] [Full Text] [Related]
13. The antiinflammatory properties of medroxyprogesterone acetate.
Rachoń D
Circulation; 2002 Nov; 106(22):e185; author reply e185. PubMed ID: 12451020
[No Abstract] [Full Text] [Related]
14. Interleukin-7 is associated with monocyte chemoattractant protein-1 and soluble E-selectin levels in peripheral blood of newly post-menopausal women.
Yasui T; Saijo A; Uemura H; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
J Reprod Immunol; 2009 Jul; 81(1):97-102. PubMed ID: 19501916
[TBL] [Abstract][Full Text] [Related]
15. Importance of the progestogen added to the estrogen in hormone therapy.
Lauritzen C
Climacteric; 2005 Dec; 8(4):398-400. PubMed ID: 16390775
[No Abstract] [Full Text] [Related]
16. Post hoc magnetic resonance imaging cannot justify the conclusions of WHIMS.
Naftolin F; King J; Morrison JH
Gynecol Endocrinol; 2010 Jun; 26(6):391-2. PubMed ID: 20175707
[No Abstract] [Full Text] [Related]
17. Summaries for patients. Postmenopausal hormone therapy and blood sugar.
Ann Intern Med; 2003 Jan; 138(1):I10. PubMed ID: 12513063
[No Abstract] [Full Text] [Related]
18. Effect of short-term estrogen with and without progesterone therapy on circulating markers of endothelial activation and injury in postmenopausal women with unstable angina pectoris.
Chou ET; Schulman SP; Thiemann DR; Sohn RH; Bellantoni MF; Rade JJ
Am J Cardiol; 2003 May; 91(10):1240-2. PubMed ID: 12745110
[No Abstract] [Full Text] [Related]
19. Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.
Nas T; Sargon MF; Celik HH; Keskin PO; Gürsoy RH; Biberoglu K
Saudi Med J; 2007 Dec; 28(12):1917-9. PubMed ID: 18060233
[No Abstract] [Full Text] [Related]
20. From the Food and Drug Administration.
Crawford LM
JAMA; 2002 Oct; 288(13):1579. PubMed ID: 12350176
[No Abstract] [Full Text] [Related]
[Next] [New Search]
